Trial intelligence / Profile preview

Levocetirizine Efficacy and QoL in Seasonal Allergic Rhinitis

NCT00653224Phase 4Completed

Sponsor
UCB
Start
Apr 2008
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levocetirizine in seasonal allergic rhinitis (SAR), sponsored by UCB. Started Apr 2008; status: completed.

02

Drugs

levocetirizine
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT00653224.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00653224.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call